Pulse Biosciences, Inc (PLSE)

Last Closing Price: 8.71 (2024-03-28)

Company Description

Pulse Biosciences, Inc. is a medical device company. It is engaged in developing a novel and proprietary tissue treatment platform using Nano-Pulse Electro-Signaling. NPES provide effective local tumor control and to initiate an adaptive immune response. The company deploy NPES platform applications which include human oncology, dermatology, aesthetics and other minimally invasive applications. Pulse Biosciences, Inc. is based in Burlingame, California.

Financials, Fundamental Metrics & Ratios
Revenue (Most Recent Fiscal Year) $0.70M
Net Income (Most Recent Fiscal Year) $-58.51M
PE Ratio (Current Year Earnings Estimate) --
PE Ratio (Trailing 12 Months) --
PEG Ratio (Long Term Growth Estimate) --
Price to Sales Ratio (Trailing 12 Months) --
Price to Book Ratio (Most Recent Quarterly Book Value per Share) 8.84
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) --
Pre-Tax Margin (Trailing 12 Months) --
Net Margin (Trailing 12 Months) --
Return on Equity (Trailing 12 Months) -154.33%
Return on Assets (Trailing 12 Months) -53.29%
Current Ratio (Most Recent Fiscal Quarter) 9.50
Quick Ratio (Most Recent Fiscal Quarter) 9.50
Debt to Common Equity (Most Recent Fiscal Quarter) 0.00
Inventory Turnover (Trailing 12 Months) 51.69
Book Value per Share (Most Recent Fiscal Quarter) $-0.06
Earnings per Share (Most Recent Fiscal Quarter) --
Earnings per Share (Most Recent Fiscal Year) --
Diluted Earnings per Share (Trailing 12 Months) $-0.92
Stock
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Common Shares Outstanding 55.08M
Free Float 16.69M
Market Capitalization $462.68M
Average Volume (Last 20 Days) 0.15M
Beta (Past 60 Months) 1.69
Percentage Held By Insiders (Latest Annual Proxy Report) 69.70%
Percentage Held By Institutions (Latest 13F Reports) 76.95%
Annual Dividend (Based on Last Quarter) $0.00
Dividend Yield (Based on Last Quarter) 0.00%